Recent in vivo interaction screening studies have demonstrated that plexin B2 expressed by hepatocytes interacts with class IV semaphorins on tumor cells, leading to the upregulation of KLF4, which subsequently promote MET and facilitates tumor metastasis [145]. Here, KLF4 is linked to neoplasm.